PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among others.
Pfizer Investigational Site, Baton Rouge, Louisiana, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.